Working in A&E, I see many tragic cases - but one of the worst is diagnosing a young person with advanced and incurable bowel ...

A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising ...

Researchers at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United ...

Every now and then I come across a research article that makes me say, “Wow.” Here’s one of those on the benefits of fiber for cancer patients — and all of us. Researchers found that every 5-gram ...

The popularity of probiotics has seen a remarkable rise ... Does Bacillus coagulans have any potential benefits for cancer patients? Some studies suggest that Bacillus coagulans may have potential ...

However, a bookshelf isn't necessarily where you should put them; we would always recommend placing them on dedicated speaker stands to ensure they sound their best. Larger speakers might give you a ...

Texas hospitals must ask patients starting Friday whether they are in the U.S. legally and track the cost of treating people without legal status following an order by Republican Gov. Greg Abbott ...

Struggling with mobility and comfort? You may want to consult your doctor about these vitamins and supplements for joint health. Hedy Phillips CNET Contributor Hedy Phillips is a freelance ...

The best laptop for engineering students will power through just about every task you can throw at it, from running office apps to complex datasets and CAD projects. This month, we've re-assessed ...

The best laptop for graphic design delivers color accurate screens and top-tier specs for running Photoshop, Illustrator, Affinity and more. My team and I have reviewed hundreds of design ...

The tickets will go to a pediatric cancer patient and his family, the Yankees said ahead of the game. The tickets used last night by the two ejected fans (plus others in that section) have been re ...

Prof. Carmi concludes, "Immunotherapy has revolutionized the treatment of cancer. However, about 50% of the patients do not respond to the currently prevailing treatment—the protein PD1.